Telomerase activity in pure pancreatic juice for the diagnosis of pancreatic cancer may be complementary to K-ras mutation

Gastrointestinal Endoscopy

Volumn 51, Issue 6, 2000, Pages 708-713

  Myung, Seung Jae ^a   Kim, Myung Hwan ^a,b   Kim, Yeon Suk ^a   Kim, Hong Ja ^a   Park, Eun Taek ^a   Yoo, Kyo Sang ^a   Lim, Byeung Cheol ^a   Seo, Dong Wan ^a   Lee, Sung Koo ^a   Min II, Young ^a   Kim, Ji Yeon ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; FEMALE; GENE ACTIVITY; GENE MUTATION; HUMAN; MALE; ONCOGENE K RAS; PANCREAS CANCER; PANCREAS JUICE; PRIORITY JOURNAL;

EID: 0034044070     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2000.104654     Document Type: Article

References (24)

1. Warshaw AL, Fernandez-del Castillo C. Pancreatic carcinoma. N Engl J Med 1992;326:455-65.
2. Ariyama J, Suyama M, Ogawa K, Ikari T, Nagaiwa J, Fujii D, et al. The detection and prognosis of small pancreatic carcinoma. Int J Pancreatol 1990;6:37-47.
3. Niederau C, Grendell JH. Diagnosis of pancreatic carcinoma: imaging techniques and tumor markers. Pancreas 1992;7:66-86.
4. Smit VTHBM, Boot AJM, Smits AMM, Fleuren GJ, Cornelisse CJ, Bos JL. K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinoma. Nucleic Acids Res 1988;16:7773-82.
5. Watanabe H, Sawabu N, Songur Y, Yamaguchi Y, Yamakawa O, Satomura Y, et al. Detection of K-ras point mutation at codon 12 in pure pancreatic juice for the diagnosis of pancreatic cancer by PCR-RFLP analysis. Pancreas 1996;12:18-24.
6. Iguchi H, Sugano K, Fukayama N, Ohkura H, Sadamoto K, Ohkoshi K, et al. Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer. Gastroenterology 1996;110:221-6.
7. Kondo H, Sugano K, Fukayama N, Kyogoku A, Nose H, Shimada K, et al. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma. Cancer 1994;73:1589-94.
8. Tada M, Ohashi M, Shiratori Y, Okudaira T, Komatsu Y, Kawabe T, et al. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 1996;110:227-31.
9. Rivera JA, Rail CJN, Graeme-Cook F, Fernandez-del Castillo C, Shu P, Lakey N, et al. Analysis of K-ras oncogene in chronic pancreatitis with ductal hyperplasia. Surgery 1997;121:42-9.
10. Furuya N, Kawa S, Akamatsu T, Furihata K. Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice. Gastroenterology 1997;113:593-8.
11. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985;43:405-13.
12. Mizumoto K, Suehara N, Muta T, Kitajima S, Hamasaki N, Tominaga Y, et al. Semi-quantitative analysis of telomerase in pancreatic ductal adenocarcinoma. J Gastroenterol 1996; 31:894-7.
13. Suehara N, Mizumoto K, Muta T, Tominaga Y, Shimura H, Kitajima S, et al. Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states. Clin Cancer Res 1997;3:993-8.
14. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
15. Levi S, Urbano-Ispizua A, Gill R, Thomas DM, Gilbertson J, Foster C, et al. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 1991;51:3497-502.
16. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, et al. Pancreatitis and the risk of pancreatic cancer. N Engl J Med 1993;328:1433-7.
17. Venu RP, Geenen JE, Kini M, Hogan WJ, Payne M, Johnson K, et al. Endoscopic retrograde brush cytology: a new technique. Gastroenterology 1992;102:188-99.
18. Goodale RL, Gajl-Peczalaka K, Dressel T, Samuelson J. Cytologic studies for the diagnosis of pancreatic cancer. Cancer 1981;47:1652-5.
19. Nakaizumi A, Tatsuta M, Vehara H, Yamamoto R, Takenaka A, Kishigami Y, et al. Cytologic examination of pure pancreatic juice in the diagnosis of pancreatic carcinoma. Cancer 1992;70:2610-4.
20. Hiyama E, Kodama T, Shinbara K, Iwao T, Itoh M, Hiyama K, et al. Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res 1997;57:326-31.
21. Suehara N, Mizumoto K, Kusumoto M, Niiyama H, Ogawa T, Yamaguchi K, et al. Telomerase activity detected in pancreatic juice 19 months before a tumor is detected in a patient with pancreatic cancer. Am J Gastroenterol 1998;93:1967-71.
22. Hsiang D, Friess H, Buchler MW, Ebert M, Butler J, Korc M. Absence of K-ras mutations in the pancreatic parenchyma of patients with chronic pancreatitis. Am J Surg 1997;174:242-6.
23. Orth M, Gansauge F, Gansauge S, Beger HG, Adler G, Schmid RM. K-ras mutations at codon 12 are rare events in chronic pancreatitis. Digestion 1998;59:120-4.
24. Lundblad V, Wright WE. Telomeres and telomerase: a simple picture becomes complex. Cell 1996;87:369-75.